Lexpos News

/Lexpos News

East & North Midlands and North West Pharmacy Owners: Book your place for our regional roadshows

Pharmacy owners across the East & North Midlands and the North West are invited to meet the Community Pharmacy England team to discuss the issues that matter to you. Chief Executive Janet Morrison and the team are heading to Nottingham on Tuesday 9th July and then onto Haydock on Wednesday 10th July to talk directly to [...]

The post East & North Midlands and North West Pharmacy Owners: Book your place for our regional roadshows appeared first on Community Pharmacy England.

By |June 24th, 2024|Lexpos News|Comments Off on East & North Midlands and North West Pharmacy Owners: Book your place for our regional roadshows

East & North Midlands and North West Pharmacy Owners: Book your place for our regional roadshows

Pharmacy owners across the East & North Midlands and the North West are invited to meet the Community Pharmacy England team to discuss the issues that matter to you. Chief Executive Janet Morrison and the team are heading to Nottingham on Tuesday 9th July and then onto Haydock on Wednesday 10th July to talk directly to [...]

The post East & North Midlands and North West Pharmacy Owners: Book your place for our regional roadshows appeared first on Community Pharmacy England.

By |June 24th, 2024|Lexpos News|Comments Off on East & North Midlands and North West Pharmacy Owners: Book your place for our regional roadshows

MHRA Class 4 Medicines Defect Information: Grepid 75 mg film coated tablets (Kent Pharma Livery)

Class 4 Medicines Defect Information: Grepid 75 mg film coated tablets (Kent Pharma Livery) Drug alert number: EL (24)A/24 Date issued: 24 June 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Grepid 75 mg film coated tablets (Kent Pharma Livery) Company name: PHARMATHEN S.A. Product name: [...]

The post MHRA Class 4 Medicines Defect Information: Grepid 75 mg film coated tablets (Kent Pharma Livery) appeared first on Community Pharmacy England.

By |June 24th, 2024|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Information: Grepid 75 mg film coated tablets (Kent Pharma Livery)

Medicine Supply Notification: Disopyramide (Rythmodan Retard® ) 250mg modified-release tablets and disopyramide (Rythmodan® ) 100mg capsules. Updated

1st July 2024: Updates to the further information hosted on the Medicines Supply Tool,  have been published.  Department of Health and Social Care (DHSC) has issued a medicine supply notification for Disopyramide (Rythmodan Retard®) 250mg modified-release tablets and disopyramide (Rythmodan®) 100mg capsules. MSN/2024/075 Tier 2 – medium impact Date of issue: 5th June 2024 Disopyramide [...]

The post Medicine Supply Notification: Disopyramide (Rythmodan Retard® ) 250mg modified-release tablets and disopyramide (Rythmodan® ) 100mg capsules. Updated appeared first on Community Pharmacy England.

By |June 24th, 2024|Lexpos News|Comments Off on Medicine Supply Notification: Disopyramide (Rythmodan Retard® ) 250mg modified-release tablets and disopyramide (Rythmodan® ) 100mg capsules. Updated

Data Security Toolkit: Most pharmacies have completed it ahead of deadline

Community Pharmacy England previously published new guidance to help community pharmacy owners complete the latest Data Security and Protection Toolkit. The Toolkit is used to make a pharmacy’s information governance (IG) declaration and must be completed by Sunday 30th June 2024.   The vast majority of pharmacy teams have now completed their Toolkit ahead of the [...]

The post Data Security Toolkit: Most pharmacies have completed it ahead of deadline appeared first on Community Pharmacy England.

By |June 21st, 2024|Lexpos News|Comments Off on Data Security Toolkit: Most pharmacies have completed it ahead of deadline